Inducible STAT3 NH2 Terminal Mono-ubiquitination Promotes BRD4 Complex Formation to Regulate Apoptosis

Overview

Journal Cell Signal

Date 2014 Mar 25

PMID 24657799

Citations 30

Authors

Sutapa Ray

Yingxin Zhao

Mohammad Jamaluddin

Chukwudi B Edeh

Chang Lee

Allan R Brasier

Affiliations

Soon will be listed here.

Abstract

Signal Transducers and Activator of Transcription-3 (STAT3) are latent transcription factors that are regulated by post-translational modifications (PTMs) in response to cellular activation by the IL-6 superfamily of cytokines to regulate cell cycle progression and/or apoptosis. Here we observe that STAT3 is inducibly mono-ubiquitinated and investigate its consequences. Using domain mapping and highly specific selected reaction monitoring-mass spectrometric assays, we identify lysine (K) 97 in its NH2-terminal domain as the major mono-ubiquitin conjugation site. We constructed a mono-ubiquitinated mimic consisting of a deubiquitinase-resistant monomeric ubiquitin fused to the NH2 terminus of STAT3 (ubiquitinated-STAT3 FP). In complex assays of ectopically expressed ubi-STAT3-FP, we observed enhanced complex formation with bromodomain-containing protein 4 (BRD4), a component of the activated positive transcriptional elongation factor (P-TEFb) complex. Chromatin immunoprecipitation experiments in STAT3(+/-) and STAT3(-/-) MEFs showed BRD4 recruitment to STAT3-dependent suppressor of cytokine signaling-3 gene (SOCS3). The effect of a selective small molecule inhibitor of BRD4, JQ1, to inhibit SOCS3 expression demonstrated the functional role of BRD4 for STAT3-dependent transcription. Additionally, ectopic ubiquitinated-STAT3 FP expression upregulated BCL2, BCL2L1, APEX1, SOD2, CCND1 and MYC expression indicating the role of ubiquitinated STAT3 in anti-apoptosis and cellular proliferation. Finally we observed that ubiquitinated-STAT3 FP suppressed TNFα-induced apoptotic cell death, indicating the functional importance of mono-ubiquitinated STAT3 in antiapoptotic gene expression. We conclude that STAT3 mono-ubiquitination is a key trigger in BRD4-dependent antiapoptotic and pro-proliferative gene expression programs. Thus, inhibiting the STAT3 mono-ubiquitination-BRD4 pathway may be a novel therapeutic target for the treatment of STAT3-dependent proliferative diseases.

Citing Articles

A combinatorial screening protocol for identifying novel and highly potent dual-target inhibitor of BRD4 and STAT3 for kidney cancer therapy.

Zhang S, Wu N, Geng Y, Guan L, Niu M, Li J Front Pharmacol. 2025; 16:1560559.

PMID: 40078291 PMC: 11897524. DOI: 10.3389/fphar.2025.1560559.

Inhibition of BRD4 attenuated IFNγ-induced apoptosis in colorectal cancer organoids.

Yonezawa A, Shimomura K, Okamoto K, Takeda H BMC Cancer. 2025; 25(1):136.

PMID: 39849410 PMC: 11759431. DOI: 10.1186/s12885-025-13544-y.

IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.

Pecharroman I, Sole L, Alvarez-Villanueva D, Lobo-Jarne T, Alonso-Maranon J, Bertran J EMBO J. 2023; 42(21):e114719.

PMID: 37737566 PMC: 10620764. DOI: 10.15252/embj.2023114719.

STAT3 Inhibition Attenuates MYC Expression by Modulating Co-Activator Recruitment and Suppresses Medulloblastoma Tumor Growth by Augmenting Cisplatin Efficacy In Vivo.

Rohrer K, Song H, Akbar A, Chen Y, Pramanik S, Wilder P Cancers (Basel). 2023; 15(8).

PMID: 37190167 PMC: 10136921. DOI: 10.3390/cancers15082239.

Regulation of Cell Plasticity by Bromodomain and Extraterminal Domain (BET) Proteins: A New Perspective in Glioblastoma Therapy.

Gargano D, Segatto M, Di Bartolomeo S Int J Mol Sci. 2023; 24(6).

PMID: 36982740 PMC: 10055343. DOI: 10.3390/ijms24065665.

References

Delmore J, Issa G, Lemieux M, Rahl P, Shi J, Jacobs H . BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011; 146(6):904-17. PMC: 3187920. DOI: 10.1016/j.cell.2011.08.017. View

Sherman C, Brasier A . Role of signal transducers and activators of transcription 1 and -3 in inducible regulation of the human angiotensinogen gene by interleukin-6. Mol Endocrinol. 2001; 15(3):441-57. DOI: 10.1210/mend.15.3.0609. View

Darnell Jr J . STATs and gene regulation. Science. 1997; 277(5332):1630-5. DOI: 10.1126/science.277.5332.1630. View

Bromberg J, Horvath C, Besser D, Lathem W, Darnell Jr J . Stat3 activation is required for cellular transformation by v-src. Mol Cell Biol. 1998; 18(5):2553-8. PMC: 110635. DOI: 10.1128/MCB.18.5.2553. View

Li M, Brooks C, Wu-Baer F, Chen D, Baer R, Gu W . Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science. 2003; 302(5652):1972-5. DOI: 10.1126/science.1091362. View

Bromberg J, Wrzeszczynska M, Devgan G, Zhao Y, Pestell R, Albanese C . Stat3 as an oncogene. Cell. 1999; 98(3):295-303. DOI: 10.1016/s0092-8674(00)81959-5. View

Tanaka T, Yamamoto Y, Muromoto R, Ikeda O, Sekine Y, Grusby M . PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3. Sci Signal. 2011; 4(202):ra85. DOI: 10.1126/scisignal.2001637. View

Nieto N . Oxidative-stress and IL-6 mediate the fibrogenic effects of [corrected] Kupffer cells on stellate cells. Hepatology. 2006; 44(6):1487-501. DOI: 10.1002/hep.21427. View

Dey A, Nishiyama A, Karpova T, McNally J, Ozato K . Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell. 2009; 20(23):4899-909. PMC: 2785733. DOI: 10.1091/mbc.e09-05-0380. View

10.

Bienko M, Green C, Sabbioneda S, Crosetto N, Matic I, Hibbert R . Regulation of translesion synthesis DNA polymerase eta by monoubiquitination. Mol Cell. 2010; 37(3):396-407. DOI: 10.1016/j.molcel.2009.12.039. View

11.

Zhao Y, Widen S, Jamaluddin M, Tian B, Wood T, Edeh C . Quantification of activated NF-kappaB/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring-mass spectrometry. Mol Cell Proteomics. 2011; 10(6):M111.008771. PMC: 3108844. DOI: 10.1074/mcp.M111.008771. View

12.

Zhong Z, Wen Z, Darnell Jr J . Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science. 1994; 264(5155):95-8. DOI: 10.1126/science.8140422. View

13.

Hoeller D, Crosetto N, Blagoev B, Raiborg C, Tikkanen R, Wagner S . Regulation of ubiquitin-binding proteins by monoubiquitination. Nat Cell Biol. 2006; 8(2):163-9. DOI: 10.1038/ncb1354. View

14.

Tanaka Y, Tanaka N, Saeki Y, Tanaka K, Murakami M, Hirano T . c-Cbl-dependent monoubiquitination and lysosomal degradation of gp130. Mol Cell Biol. 2008; 28(15):4805-18. PMC: 2493370. DOI: 10.1128/MCB.01784-07. View

15.

Karpiuk O, Najafova Z, Kramer F, Hennion M, Galonska C, Konig A . The histone H2B monoubiquitination regulatory pathway is required for differentiation of multipotent stem cells. Mol Cell. 2012; 46(5):705-13. DOI: 10.1016/j.molcel.2012.05.022. View

16.

Safhi M, Rutherford C, Ledent C, Sands W, Palmer T . Priming of signal transducer and activator of transcription proteins for cytokine-triggered polyubiquitylation and degradation by the A 2A adenosine receptor. Mol Pharmacol. 2010; 77(6):968-78. DOI: 10.1124/mol.109.062455. View

17.

Darnell Jr J . The JAK-STAT pathway: summary of initial studies and recent advances. Recent Prog Horm Res. 1996; 51:391-403; discussion 403-4. View

18.

Levy D, Darnell Jr J . Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol. 2002; 3(9):651-62. DOI: 10.1038/nrm909. View

19.

Ray S, Boldogh I, Brasier A . STAT3 NH2-terminal acetylation is activated by the hepatic acute-phase response and required for IL-6 induction of angiotensinogen. Gastroenterology. 2005; 129(5):1616-32. DOI: 10.1053/j.gastro.2005.07.055. View

20.

Bromberg J . Activation of STAT proteins and growth control. Bioessays. 2001; 23(2):161-9. DOI: 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0. View